Free Trial

Oncolytics Biotech (ONC) Insider Trading & Ownership

-0.04 (-2.61%)
(As of 05/28/2024 ET)

Oncolytics Biotech (TSE:ONC) Insider Buying and Selling Activity

Insider Ownership
Number Of
Insiders Buying
(Last 3 Years)
Amount Of
Insider Buying
(Last 3 Years)
Number Of
Insiders Selling
(Last 3 Years)
Get ONC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oncolytics Biotech stock? Sign up for's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ONC Insider Buying and Selling by Quarter

Oncolytics Biotech Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/16/2022Allison HagermanSenior OfficerBuy4,200C$1.16C$4,851.00
6/14/2022Kirk LookSenior OfficerBuy6,000C$1.11C$6,656.40
6/14/2022Matthew CoffeyDirectorBuy5,774C$1.08C$6,219.46
6/7/2021Angela Frances HolthamDirectorBuy7,000C$3.59C$25,123.70
(Data available from 1/1/2013 forward)

ONC Insider Trading Activity - Frequently Asked Questions

Who is on Oncolytics Biotech's Insider Roster?

The list of insiders at Oncolytics Biotech includes Allison Hagerman, Angela Frances Holtham, Kirk Look, and Matthew Coffey. Learn more on insiders at ONC.

What percentage of Oncolytics Biotech stock is owned by insiders?

3.90% of Oncolytics Biotech stock is owned by insiders. Learn more on ONC's insider holdings.

Which Oncolytics Biotech insiders have been buying company stock?

The following insiders have purchased ONC shares in the last 24 months: Allison Hagerman (C$4,851.00), Kirk Look (C$6,656.40), and Matthew Coffey (C$6,219.46).

How much insider buying is happening at Oncolytics Biotech?

Insiders have purchased a total of 15,974 ONC shares in the last 24 months for a total of C$17,726.86 bought.

More Insider Trading Tools from MarketBeat

This page (TSE:ONC) was last updated on 5/29/2024 by Staff

From Our Partners